Lampertico Pietro

Associate Professor
Competition sector



Via Della Commenda, 10/12 - Pad. Mangiagalli
20122 MILANO

Office phone number
02503 20408
02503 20409
02503 20453
Additional phone numbers
02 5503 5432
University email address



  • Preliminary experience on safety of regorafenib after sorafenib failure in recurrent hepatocellular carcinoma after liver transplantation / M. Iavarone, F. Invernizzi, C. Czauderna, M. Sanduzzi-Zamparelli, S. Bhoori, G. Amaddeo, M.A. Manini, M. Fraile López, M. Anders, M. Pinter, M.J. Blanco Rodríguez, M. Romero Cristóbal, G. Aballay Soteras, F. Piñero, G.E. Villadsen, A. Weinmann, G. Crespo, V. Mazzaferro, H. Regnault, M. De Giorgio, M.L. González-Diéguez, M.F. Donato, M. Varela, M. Wörns, J. Bruix, P. Lampertico, M. Reig. - In: AMERICAN JOURNAL OF TRANSPLANTATION. - ISSN 1600-6135. - 19:11(2019 Nov 01), pp. 3176-3184.
  • Focus on Very Late Hepatocellular Carcinoma Recurring After Liver Transplantation : a Case Report and Literature Review / F. Invernizzi, U. Maggi, S. Mazza, M. Baia, M. Nosotti, P. Mendogni, P. Muiesan, A. Cannata, M. Iavarone, F. Damarco, P. Lampertico, M.F. Donato, G. Rossi. - In: TRANSPLANTATION PROCEEDINGS. - ISSN 0041-1345. - 51:9(2019 Nov), pp. 2998-3000.
  • Minimal increases of serum alpha-foetoprotein herald HCC detection in Caucasian HBV cirrhotic patients under long-term oral therapy / A. Loglio, M. Iavarone, M. Vigano, A. Orenti, F. Facchetti, I. Cortinovis, G. Lunghi, F. Ceriotti, V. Occhipinti, M. Rumi, A. Sangiovanni, M. Colombo, P. Lampertico. - In: LIVER INTERNATIONAL. - ISSN 1478-3223. - 39:10(2019 Oct), pp. 1964-1974.
  • Excellent safety and effectiveness of high-dose myrcludex-B monotherapy administered for 48 weeks in HDV-related compensated cirrhosis : a case report of 3 patients / A. Loglio, P. Ferenci, S.C. Uceda Renteria, C.Y.L. Tham, F. van Bommel, M. Borghi, H. Holzmann, R. Perbellini, E. Trombetta, S. Giovanelli, L. Greco, L. Porretti, D. Prati, F. Ceriotti, G. Lunghi, A. Bertoletti, P. Lampertico. - In: JOURNAL OF HEPATOLOGY. - ISSN 0168-8278. - 71:4(2019 Oct), pp. 834-839.
  • Residual risk of HCC during long-term oral nucleos(t)ide analogues (NUCs) in patients with CHB : Is one NUC better than the other? / G.L.-. Wong, P. Lampertico. - In: JOURNAL OF HEPATOLOGY. - ISSN 0168-8278. - 71:3(2019 Sep), pp. 453-455.